The need for more and better science backing health claims was the central theme at a weight management and satiety seminar held in Amsterdam this week, as well as growing trepidation about health claims in Europe.
A health claim negative opinion issued by the European Food Safety Authority (EFSA) is being challenged by the company that submitted it on the grounds its wording was changed without its knowledge or consent.
An ambitious article 14 health claim dossier submitted by Italian-based Soremartec Italia S.r.l. Gruppo Ferrero that sought to link chocolate consumption and growth in children has drawn a negative opinion from the European Food Safety Authority.
The European Food Safety Authority (EFSA) has issued a negative opinion to global cranberry leader Ocean Spray for an article 14 health claim relating consumption of cranberry and urinary tract infection (UTI) in women.
The European Union health and nutrition claims regulation deadline of January, 2010, is coming under increasing pressure as European risk assessors and risk managers lurch under the sheer weight of processing more than 4000 generic article 13 claims.
A major European trade group has chimed in with criticism of the latest version of the European Union health and nutrition claims article 13 list, adding to industry concern that claims are being removed or modified without clear explanation from authorities.
The European heart health ingredients market is set for buoyant growth despite a climate of regulatory uncertainty, according to market research conducted by Frost & Sullivan, which valued the market at €421m in 2007 and growing at 20 per cent.
The European Food Safety Authority (EFSA) has affirmed the importance of calcium and vitamin D for bone health by approving an article 14 children’s health claim submitted under the EU health and nutrition regulation by Danone’s Spanish arm.
EFSA has published the list of functional health claims it has received from the Commission to be assessed under article 13 of the new health claims regulation; while the publication has been cautiously welcomed by industry, doubts remain about meeting...